The physiology and pathophysiology of nitric oxide in the brain

被引:590
作者
Guix, FX [1 ]
Uribesalgo, I [1 ]
Coma, M [1 ]
Muñoz, FJ [1 ]
机构
[1] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Unitat Senyalitz Cellular, Lab Fisiol Mol, E-08003 Barcelona, Spain
关键词
D O I
10.1016/j.pneurobio.2005.06.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Nitric oxide (NO) is a molecule with pleiotropic effects in different tissues. NO is synthesized by NO synthases (NOS), a family with four major types: endothelial, neuronal, inducible and mitochondrial. They can be found in almost all the tissues and they can even co-exist in the same tissue. NO is a well-known vasorelaxant agent, but it works as a neurotransmitter when produced by neurons and is also involved in defense functions when it is produced by immune and glial cells. NO is thermodynamically unstable and tends to react with other molecules, resulting in the oxidation, nitrosylation or nitration of proteins, with the concomitant effects on many cellular mechanisms. NO intracellular signaling involves the activation of guanylate cyclase but it also interacts with MAPKs, apoptosis-related proteins, and mitochondrial respiratory chain or anti-proliferative molecules. It also plays a role in post-translational modification of proteins and protein degradation by the proteasome. However, under pathophysiological conditions NO has damaging effects. In disorders involving oxidative stress, such as Alzheimer's disease, stroke and Parkinson's disease, NO increases cell damage through the formation of highly reactive peroxynitrite. The paradox of beneficial and damaging effects of NO will be discussed in this review. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:126 / 152
页数:27
相关论文
共 409 条
[81]   NITRIC-OXIDE MEDIATES GLUTAMATE NEUROTOXICITY IN PRIMARY CORTICAL CULTURES [J].
DAWSON, VL ;
DAWSON, TM ;
LONDON, ED ;
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6368-6371
[82]   Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration [J].
de la Monte, SM ;
Lu, BX ;
Sohn, YK ;
Etienne, D ;
Kraft, J ;
Ganju, N ;
Wands, JR .
NEUROBIOLOGY OF AGING, 2000, 21 (02) :309-319
[83]   Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of ceramide [J].
De Nadai, C ;
Sestili, P ;
Cantoni, O ;
Lièvremont, JP ;
Sciorati, C ;
Barsacchi, R ;
Moncada, S ;
Meldolesi, J ;
Clementi, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5480-5485
[84]  
DELAMONTE SM, 2000, ANN NY ACAD SCI, V90, P61
[85]   Activation of nitric oxide synthase by ischaemia in the perfused heart [J].
Depre, C ;
Fierain, L ;
Hue, L .
CARDIOVASCULAR RESEARCH, 1997, 33 (01) :82-87
[86]   Transporters for cationic amino acids in animal cells:: Discovery, structure, and function [J].
Devés, R ;
Boyd, CAR .
PHYSIOLOGICAL REVIEWS, 1998, 78 (02) :487-545
[87]   Ceramide 2 (N-acetyl sphingosine) is associated with reduction in Bcl-2 protein levels by Western blotting and with apoptosis in cultured human keratinocytes [J].
Di Nardo, A ;
Benassi, L ;
Magnoni, C ;
Cossarizza, A ;
Seidenari, S ;
Giannetti, A .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (03) :491-497
[88]   Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation [J].
Dimmeler, S ;
Fleming, I ;
Fisslthaler, B ;
Hermann, C ;
Busse, R ;
Zeiher, AM .
NATURE, 1999, 399 (6736) :601-605
[89]   ENDOTHELIAL NITRIC-OXIDE SYNTHASE LOCALIZED TO HIPPOCAMPAL PYRAMIDAL CELLS - IMPLICATIONS FOR SYNAPTIC PLASTICITY [J].
DINERMAN, JL ;
DAWSON, TM ;
SCHELL, MJ ;
SNOWMAN, A ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4214-4218
[90]   The kinetics and regulation of the induction of type II nitric oxide synthase and nitric oxide in human fetal glial cell cultures [J].
Ding, M ;
Merrill, JE .
MOLECULAR PSYCHIATRY, 1997, 2 (02) :117-119